Abstract
timeliness in ART initiation, ensuring continuous engagement of patients with the health care system 66 for periodic drug refills and running monitoring tests are critical to the success of this rapid ART scale-67 up. In spite of all this, loss to follow up of patients after ART initiation remains a great challenge.
68
Systematic reviews of studies on the rapidly expanding ART programs in SSA illustrated that about 69 60-65% of patients were retained in HIV care at 2 to 3 years after starting ART [15, 16] . In settings 70 where patients start ART instantly after a positive HIV test, there is a possibility of offsetting the 71 benefits associated with the immediate initiation when patients do not return to the HIV clinics. optimal levels of ART adherence and retention of mothers in care [17 ,18] . LTFU is associated with 80 drug resistance, and comparatively poor long-term treatment outcomes, including mortality [19] . In 81 resource constrained SSA countries, enhanced ART initiation will benefit from data characterizing 82 retention of patients in typical clinical settings. To date however, a few studies have explored loss to 83 follow up and associated factors in a typical HIV clinic practicing test and treat. Most of the data 84 currently available are derived from implementation of test-and-treat in research settings. In this study, 85 we set out to study the cumulative incidence and incidence rate of loss to follow up, and factors 86 associated with loss to follow up in a primary healthcare clinic that has practiced test and treat since 87 2012.
88

Methodology
89
Study design
90
This was a retrospective cohort study utilizing data collected on patients who were diagnosed with 
125
After this period, the guidelines changed to ART initiation based on CD4 cell count ≤500 cells/ml, 
Study participants
130
We included all patients aged ≥18 years, tested and initiated on ART from 01 st January 2012 to 31 st
131
December 2016 regardless of whether or not they tested at Masaka regional referral hospital. We 132 excluded patients who transferred in from other HIV clinics because we were not able to confirm their
133
HIV test and ART initiation dates with certainty, and patients with prior ART history (for example 134 those that had ever used PEP since we could not ascertain the period when they were on medication).
135
In addition, patients <18 years were excluded because they are children according to the Ugandan 136 policy, but also because they do not decide on health service delivery options on their own but rather 137 through their parents/care givers or guardians.
Variables, data sources and measurement
139
The primary outcome was loss to follow up defined as failure of the client to show up at the Masaka 140 clinic for at least 90 days from the date of their last scheduled appointment [37, 39] Table 2 indicates the IR of loss to follow up by patients' characteristics. The incidence rate of 214 LTFU was 10.9/100 pyo in the T&T group compared to 5.7/100 pyo in the delayed ART group.
215
There was no difference in incidence rate of LTFU among males 7.4/100 pyo (95% CI, 6.7-216 8.1/100pyo) and females -7.7/100 pyo (95% CI, 7.2-8.3/100pyo).
217
The IR was highest at 14.6/100 pyo (95% CI, 13.3-16.1/100pyo) in patients that initiated ART 218 in the age group 18-24 years and was lowest at 4.2/100 pyo (95% CI, 3.2-5.7/100pyo) among 219 those aged ≥50 years. In patients with access to a telephone set, the IR was 6.6/100 pyo (95% CI, 
Discussion
258
In this retrospective observation study of a primary healthcare clinic practicing test and treat, we retained has been reported in a study in rural Uganda [29] and an almost comparable proportion in another study in Malawi [30] both at one year. Differences in proportions reported in these studies to 
